Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fred Broadway currently holds 28,350 shares of CardioNet, Inc. (BEAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Broadway has been a net seller of BEAT stock. They have purchased $0 and sold $9.3M worth of shares.
Fred Broadway's most recent insider trade was on Feb 9, 2021, when they sold 29,375 shares at $72.00 per share.
Fred Broadway serves as Executive at CardioNet, Inc. (BEAT). They have executed 44 insider transactions totaling $9.3M over their tenure at the company.
Fred Broadway holds the position of Executive at CardioNet, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Fred Broadway has shown a selling trading pattern, with $0 in total purchases and $9.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Fred Broadway was on Sep 28, 2018, when they sold $5.9M worth of BEAT shares. This transaction involved 90,113 shares at $65.00 per share.
Fred Broadway currently owns 28,350 shares of CardioNet, Inc. (BEAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fred Broadway's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fred Broadway has 44 Form 4 filings on record as an insider at CardioNet, Inc..
Set alerts for Fred Broadway and 40,000+ other insiders.